Kata® on prescription
Inhalation App raises therapy standard for respiratory diseases
With the “Kata®” app, patients and pneumologists are provided with an innovative inhalation assistant that reduces the amount of treatment required for chronic respiratory diseases and improves patient care in the long term. Installed on patients’ smartphones, it reduces application errors with inhalers and improves the success of therapy.
The first app for inhalation therapy on prescription
Kata® is the ideal support for a continuous therapy overview. The app documents the patient’s applications and health data and allows him to export the data for sharing with the doctor.
With the coming into effect of the German Digitale-Versorgung-Gesetz (DVG) on December 19, 2019, the “App on prescription” for patients was introduced into German health care. This means that approximately 73 million people insured in the German statutory health insurance (GKV) have a right to be provided with digital health applications (DiGA), which can be prescribed by doctors and psychotherapists and are reimbursed by the local health insurance companies.
Kata® was one of the first health apps to achieve the Europe-wide CE marking for digital medical products. It is therefore qualified for the approval procedure in Germany.
Practice Package now available for reservation
We support pneumologists and general practitioners in the introduction and implementation of DiGAs in their practice so that they have as little further work and time as possible. As soon as prescriptions for the app are legally regulated and the first DiGAs are listed, it’s go time. We have put together a comprehensive set of information and will be happy to advise you on the subject. Of course, we also offer inhalation therapy training for you and your practice staff. Write to us using the contact form or simply send us an e-mail at email@example.com – we will be happy to contact you.